thymidine has been researched along with Meningioma in 20 studies
Meningioma: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The growth of human cerebral meningiomas depends on various growth factors, including epidermal growth factor (EGF), transforming growth factor (TGF)-alpha and TGF-beta, platelet-derived growth factor (PDGF)-BB, insulin-like growth factor (IGF)-I and IGF-II, and acidic and basic fibroblast growth factors." | 7.69 | Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop. ( Adams, EF; Bickel, A; Fahlbusch, R; Gauer, S; Hren, J; Kiesewetter, F; Schrell, UM, 1995) |
| " In this study, Northern blots, immunohistochemistry, TGF beta radioreceptor assays, TGF beta receptor affinity labeling and [3H] thymidine incorporation were used to evaluate whether primary cell cultures of human meningiomas synthesize the three TGF beta isoforms, bear TGF beta receptors, and respond to TGF beta." | 7.68 | Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. ( Federspiel, CF; Gold, LI; Johnson, MD; Moses, HL, 1992) |
| " We studied the effects of BQ-123, a selective ETA receptor antagonist, on 125I-endothelin-1 (125I-ET-1) binding to cell surface receptors in surgically exercised human meningiomas and on ET-1-induced DNA synthesis in cultured human meningioma cells in vitro, using a quantitative receptor autoradiographic technique with radioluminography and 3H-thymidine incorporation, respectively." | 3.69 | A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells. ( Anda, T; Himeno, A; Khalid, H; Kitagawa, N; Niwa, M; Shibata, S; Taniyama, K; Tsutsumi, K; Yamaga, S, 1994) |
| "The growth of human cerebral meningiomas depends on various growth factors, including epidermal growth factor (EGF), transforming growth factor (TGF)-alpha and TGF-beta, platelet-derived growth factor (PDGF)-BB, insulin-like growth factor (IGF)-I and IGF-II, and acidic and basic fibroblast growth factors." | 3.69 | Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop. ( Adams, EF; Bickel, A; Fahlbusch, R; Gauer, S; Hren, J; Kiesewetter, F; Schrell, UM, 1995) |
| " In this study, Northern blots, immunohistochemistry, TGF beta radioreceptor assays, TGF beta receptor affinity labeling and [3H] thymidine incorporation were used to evaluate whether primary cell cultures of human meningiomas synthesize the three TGF beta isoforms, bear TGF beta receptors, and respond to TGF beta." | 3.68 | Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells. ( Federspiel, CF; Gold, LI; Johnson, MD; Moses, HL, 1992) |
| "Meningioma is a generally benign tumor derived from arachnoid tissue." | 1.28 | Expression of PDGF beta-receptors in human meningioma cells. ( Hermansson, M; Nistér, M; Pontén, J; Wang, JL; Westermark, B, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, MD | 3 |
| Okedli, E | 1 |
| Woodard, A | 2 |
| Toms, SA | 1 |
| Allen, GS | 1 |
| Okediji, E | 1 |
| Berdel, WE | 1 |
| Greiner, E | 1 |
| Fink, U | 1 |
| Zänker, KS | 1 |
| Stavrou, D | 1 |
| Trappe, A | 1 |
| Fahlbusch, R | 2 |
| Reichert, A | 1 |
| Rastetter, J | 1 |
| Mauro, A | 1 |
| Di Sapio, A | 1 |
| Mocellini, C | 1 |
| Schiffer, D | 1 |
| Kitagawa, N | 2 |
| Tsutsumi, K | 2 |
| Niwa, M | 2 |
| Yamaga, S | 1 |
| Anda, T | 1 |
| Khalid, H | 1 |
| Himeno, A | 2 |
| Taniyama, K | 2 |
| Shibata, S | 2 |
| Schrell, UM | 1 |
| Gauer, S | 1 |
| Kiesewetter, F | 1 |
| Bickel, A | 1 |
| Hren, J | 1 |
| Adams, EF | 1 |
| Yamashita, K | 1 |
| Kurihara, M | 1 |
| Kawano, T | 1 |
| Yasunaga, A | 1 |
| Friend, KE | 1 |
| Radinsky, R | 1 |
| McCutcheon, IE | 1 |
| Federspiel, CF | 1 |
| Gold, LI | 1 |
| Moses, HL | 1 |
| Koper, JW | 1 |
| Markstein, R | 1 |
| Kohler, C | 1 |
| Kwekkeboom, DJ | 1 |
| Avezaat, CJ | 1 |
| Lamberts, SW | 1 |
| Reubi, JC | 1 |
| Wang, JL | 1 |
| Nistér, M | 1 |
| Hermansson, M | 1 |
| Westermark, B | 1 |
| Pontén, J | 1 |
| Splawinski, J | 1 |
| Michna, M | 1 |
| Palczak, R | 1 |
| Konturek, S | 1 |
| Splawinska, B | 1 |
| Kunert-Radek, J | 1 |
| Stepien, H | 1 |
| Radek, A | 1 |
| Pawlikowski, M | 1 |
| Kunz, J | 1 |
| Gottschalk, J | 1 |
| Jänisch, W | 1 |
| Schulz, W | 1 |
| Westphal, M | 1 |
| Herrmann, HD | 1 |
| Takahashi, T | 1 |
| Takeno, Y | 1 |
| Takaki, R | 1 |
| Kajiyama, T | 1 |
| Takii, M | 1 |
| Sano, K | 1 |
| Hoshino, T | 1 |
| Nagai, M | 1 |
| Ostertag, B | 1 |
| Wahlström, T | 1 |
| Saksela, E | 2 |
| Troupp, H | 1 |
| Holmström, T | 1 |
| Nyström, S | 1 |
| Saxén, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of the Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Malignant Pleural Mesothelioma[NCT02303899] | Phase 2 | 22 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 other studies available for thymidine and Meningioma
| Article | Year |
|---|---|
Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.
Topics: Adult; Aged; Androstadienes; Anticoagulants; Becaplermin; Enzyme Inhibitors; Female; Humans; Male; M | 2002 |
Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways.
Topics: Aged; Antibodies; Cell Division; Cerebrospinal Fluid; DNA-Binding Proteins; Female; Humans; Male; Me | 2004 |
Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Cell Survival; Cells, Cultured; Glioma; Histocy | 1984 |
Control of meningioma cell growth by platelet-derived growth factor (PDGF).
Topics: Antibodies, Monoclonal; Blotting, Northern; Cell Division; Culture Media, Conditioned; Gene Expressi | 1995 |
A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells.
Topics: Amino Acid Sequence; Cell Division; Endothelin Receptor Antagonists; Endothelins; Humans; Iodine Rad | 1994 |
Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Topics: Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Division; DNA; Dose-Response Relationship, Drug | 1995 |
Expression of a functional endothelin (ETA) receptor in human meningiomas.
Topics: Adolescent; Aged; Autoradiography; Binding Sites; Female; Humans; Male; Meningeal Neoplasms; Meningi | 1994 |
Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist.
Topics: Adult; Aged; Aged, 80 and over; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Humans; | 1999 |
Transforming growth factor-beta and transforming growth factor beta-receptor expression in human meningioma cells.
Topics: Blotting, Northern; Cross-Linking Reagents; Humans; Immunohistochemistry; Meningeal Neoplasms; Menin | 1992 |
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.
Topics: Adenylyl Cyclase Inhibitors; Bucladesine; Cell Division; Colforsin; Cyclic AMP; DNA Replication; Dos | 1992 |
Expression of PDGF beta-receptors in human meningioma cells.
Topics: Adult; Aged; Arachnoid; Blotting, Northern; Cells, Cultured; Female; Humans; Immunohistochemistry; I | 1990 |
Angiogenesis: quantitative assessment by the chick chorioallantoic membrane assay.
Topics: Allantois; Animals; Chick Embryo; Chorion; DNA; Epidermal Growth Factor; Extraembryonic Membranes; F | 1988 |
Somatostatin suppression of meningioma cell proliferation in vitro.
Topics: Adult; Cell Division; Female; Humans; In Vitro Techniques; Meningeal Neoplasms; Meningioma; Middle A | 1987 |
[Cell proliferation and glial fibrillary acidic protein in brain tumors].
Topics: Adolescent; Adult; Astrocytoma; Autoradiography; Brain Neoplasms; Cell Division; Cell Transformation | 1986 |
Epidermal growth factor--receptors on cultured human meningioma cells.
Topics: Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Humans; Meningioma; Thymidine | 1986 |
Screening of carcinostatic agents in organ culture.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma; Cerebellar Neoplasms; Chickens; Culture Techniques; | 1968 |
Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; DNA; Floxuridine; Fluorouracil; | 1968 |
[Radiation effects on the embryonal and abnormal development of the central nervous system in mammals].
Topics: Animals; Bone and Bones; Brain; Brain Neoplasms; Cell Differentiation; Central Nervous System; Cereb | 1972 |
Cell-bound antiglial immunity in patients with malignant tumors of the brain.
Topics: Antigens, Neoplasm; Astrocytoma; Autoradiography; Brain Neoplasms; Cells, Cultured; Chromium Isotope | 1973 |
Growth behaviour of human brain tumours in matrix cultures in fresh autologous serum.
Topics: Autoradiography; Blood; Brain Neoplasms; Culture Media; Fibrin Foam; Glioma; Growth; Humans; Meningi | 1970 |